Geniposide Alleviates Traumatic Brain Injury in Rats Via Anti-Inflammatory Effect and MAPK/NF-kB Inhibition

  • Jianwei Yuan
  • Jinghua Zhang
  • Juan Cao
  • Guangxing Wang
  • Hansheng BaiEmail author
Original Research


We aimed to investigate whether geniposide, a main component extracted from Gardenia jasminoides Ellis fruit, could exert neuroprotective functions against traumatic brain injury (TBI). Enzyme-linked immunosorbent assay (ELISA) was used for detection of plasma cytokines. Real-time polymerase chain reaction (RT-PCR) was employed for measurements of mRNA levels of cytokines. Neurological outcomes were evaluated by modified neurological severity score (mNSS) and Rota-Rod. Blood–brain barrier (BBB) integrity and brain edema were assessed. Protein expression was tested by Western blot. The plasma levels of interleukin (IL)-1β, IL-6, IL-8 and IL-10 were all elevated in patients with TBI compared to those of healthy controls. TBI rats treated with geniposide showed lower mNSS and longer fall latency time than untreated TBI rats. BBB integrity was maintained and brain edema was reduced by geniposide treatment in TBI rats. Plasma levels of IL-1β, IL-6 and IL-8 were significantly repressed by geniposide treatment in TBI rats, whereas IL-10 level was upregulated. mRNA expression levels of these cytokines in the brain tissues of TBI rats exhibited the same trends of changes. By testing p38 mitogen-activated protein kinase and NF-κB p65 activities, it was observed that phosphorylated (p)-p38 and p-p65 were dramatically inhibited by geniposide. In conclusion, geniposide exerts neuroprotective functions against TBI by inhibiting p-p38 and p-p65.


Mitogen-activated protein kinase (MAPK) NF-kappaB (NF-κB) Traumatic brain injury (TBI) Geniposide 



Not applicable.

Author Contributions

Did the experiments and analyzed the data: JY, JZ, JC and GW; Designed the study and wrote the manuscript: HB. All authors approved the final submission.



Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Informed Consent

All participants in this study were informed and gave an informed written consent.

Research Involving Human Participants and/or Animals

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.


  1. Abdul-Muneer P, Chandra N, Haorah J (2015) Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol 51(3):966–979CrossRefGoogle Scholar
  2. Bachstetter AD, Rowe RK, Kaneko M, Goulding D, Lifshitz J, Van Eldik LJ (2013) The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury. J Neurosci 33(14):6143–6153CrossRefGoogle Scholar
  3. Bergold PJ (2016) Treatment of traumatic brain injury with anti-inflammatory drugs. Exp Neurol 275:367–380CrossRefGoogle Scholar
  4. Blennow K, Hardy J, Zetterberg H (2012) The neuropathology and neurobiology of traumatic brain injury. Neuron 76(5):886–899CrossRefGoogle Scholar
  5. Brown GC, Vilalta A (2015) How microglia kill neurons. Brain Res 1628:288–297CrossRefGoogle Scholar
  6. Buchanan MM, Hutchinson M, Watkins LR, Yin H (2010) Toll-like receptor 4 in CNS pathologies. J Neurochem 114(1):13–27PubMedPubMedCentralGoogle Scholar
  7. Cao S, Zhang X, Edwards JP, Mosser DM (2006) NF-κB1 (p50) homodimers differentially regulate pro-and anti-inflammatory cytokines in macrophages. J Biol Chem 281(36):26041–26050CrossRefGoogle Scholar
  8. Chen Y, Zhang Y, Li L, Hölscher C (2015) Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson’s disease. Eur J Pharmacol 768:21–27CrossRefGoogle Scholar
  9. Corps KN, Roth TL, McGavern DB (2015) Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72(3):355–362CrossRefGoogle Scholar
  10. Corrigan JD, Selassie AW, Orman JAL (2010) The epidemiology of traumatic brain injury. J Head Trauma Rehabil 25(2):72–80CrossRefGoogle Scholar
  11. DePalma RG, Burris DG, Champion HR, Hodgson MJ (2005) Blast injuries. N Engl J Med 352(13):1335–1342CrossRefGoogle Scholar
  12. Ferreira LCB, Regner A, Miotto KDL, Moura Sd, Ikuta N, Vargas AE, Chies JAB, Simon D (2014) Increased levels of interleukin-6,-8 and-10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj 28(10):1311–1316CrossRefGoogle Scholar
  13. Hellewell S, Semple BD, Morganti-Kossmann MC (2016) Therapies negating neuroinflammation after brain trauma. Brain Res 1640:36–56CrossRefGoogle Scholar
  14. Jones NC, Prior MJ, Burden-Teh E, Marsden CA, Morris PG, Murphy S (2005) Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes. Eur J Neurosci 22(1):72–78CrossRefGoogle Scholar
  15. Kokiko-Cochran ON, Godbout JP (2018) The inflammatory continuum of traumatic brain injury and Alzheimer’s disease. Front Immunol 9:672CrossRefGoogle Scholar
  16. Koo H-J, Song YS, Kim H-J, Lee Y-H, Hong S-M, Kim S-J, Kim B-C, Jin C, Lim C-J, Park E-H (2004) Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 495(2–3):201–208CrossRefGoogle Scholar
  17. Kou Z, VandeVord PJ (2014) Traumatic white matter injury and glial activation: from basic science to clinics. Glia 62(11):1831–1855CrossRefGoogle Scholar
  18. Li F, Li W, Li X, Li F, Zhang L, Wang B, Huang G, Guo X, Wan L, Liu Y (2016) Geniposide attenuates inflammatory response by suppressing P2Y14 receptor and downstream ERK1/2 signaling pathway in oxygen and glucose deprivation-induced brain microvascular endothelial cells. J Ethnopharmacol 185:77–86CrossRefGoogle Scholar
  19. Li C, Wang X, Cheng F, Du X, Yan J, Zhai C, Mu J, Wang Q (2019) Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system. Eur J Pharmacol 854:224–231CrossRefGoogle Scholar
  20. Liao Y, Liu P, Guo F, Zhang Z-Y, Zhang Z (2013) Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS ONE 8(7):e68963CrossRefGoogle Scholar
  21. Lu W, Zhao Y, Kong Y, Zhang W, Ma W, Li W, Wang K (2018) Geniposide prevents H2O2-induced oxidative damage in melanocytes by activating the PI 3K–Akt signalling pathway. Clin Exp Dermatol 43(6):667–674CrossRefGoogle Scholar
  22. Maas AI, Roozenbeek B, Manley GT (2010) Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 7(1):115–126CrossRefGoogle Scholar
  23. Manson J, Thiemermann C, Brohi K (2012) Trauma alarmins as activators of damage-induced inflammation. Br J Surg 99(S1):12–20CrossRefGoogle Scholar
  24. Norden DM, Trojanowski PJ, Walker FR, Godbout JP (2016) Insensitivity of astrocytes to interleukin 10 signaling following peripheral immune challenge results in prolonged microglial activation in the aged brain. Neurobiol Aging 44:22–41CrossRefGoogle Scholar
  25. O’Connor CA, Cernak I, Vink R (2005) Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Res 1062(1–2):171–174CrossRefGoogle Scholar
  26. Plesnila N (2016) The immune system in traumatic brain injury. Curr Opin Pharmacol 26:110–117CrossRefGoogle Scholar
  27. Russo MV, McGavern DB (2016) Inflammatory neuroprotection following traumatic brain injury. Science 353(6301):783–785CrossRefGoogle Scholar
  28. Shohami E, Gallily R, Mechoulam R, Bass R, Ben-Hur T (1997) Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J Neuroimmunol 72(2):169–177CrossRefGoogle Scholar
  29. Smith DH, Johnson VE, Stewart W (2013) Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol 9(4):211CrossRefGoogle Scholar
  30. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P (2008) Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283(17):11689–11699CrossRefGoogle Scholar
  31. Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1–12CrossRefGoogle Scholar
  32. Woodcock T, Morganti-Kossmann C (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18CrossRefGoogle Scholar
  33. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM (2014) Very early administration of progesterone for acute traumatic brain injury. N Engl J Med 371(26):2457–2466CrossRefGoogle Scholar
  34. Xiong LL, Tan Y, Ma HY, Dai P, Qin YX, Yang RA, Xu YY, Deng Z, Zhao W, Xia QJ, Wang TH, Zhang YH (2016) Administration of SB239063, a potent p38 MAPK inhibitor, alleviates acute lung injury induced by intestinal ischemia reperfusion in rats associated with AQP4 downregulation. Int Immunopharmacol 38:54–60. CrossRefPubMedGoogle Scholar
  35. Xu B, Li YL, Xu M, Yu CC, Lian MQ, Tang ZY, Li CX, Lin Y (2017) Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function. Acta Pharmacol Sin 38(5):688–698. CrossRefPubMedPubMedCentralGoogle Scholar
  36. Zhao C, Zhang H, Li H, Lv C, Liu X, Li Z, Xin W, Wang Y, Zhang W (2017) Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice. Neuropharmacology 116:18–29CrossRefGoogle Scholar
  37. Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro-and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7(1):22–30CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Jianwei Yuan
    • 1
  • Jinghua Zhang
    • 2
  • Juan Cao
    • 2
  • Guangxing Wang
    • 1
  • Hansheng Bai
    • 1
    Email author
  1. 1.Heze Municipal Hospital of Shandong ProvinceHezeChina
  2. 2.Heze Medical CollegeHezeChina

Personalised recommendations